Gagner, Michel https://orcid.org/0000-0001-6068-0333
Article History
Received: 18 July 2021
Revised: 24 July 2021
Accepted: 27 July 2021
First Online: 6 August 2021
Declarations
:
: The author is a consultant for NovoNordisk and consultant and stocks owner with Lexington Medical, Inc. and GT Metabolic Solutions, Inc.